A Phase 1 Open-label, Cross-over Study to Assess the Effects of Food on PC14586 Pharmacokinetics in Healthy Volunteers and to Assess PC14586 Pharmacokinetics in Healthy Japanese Volunteers Living in the US
Latest Information Update: 20 Jan 2025
Price :
$35 *
At a glance
- Drugs Rezatapopt (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics; Registrational
- Sponsors PMV Pharmaceuticals
- 19 Dec 2022 Status changed from recruiting to completed.
- 23 Feb 2022 New trial record